Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0184 Transporter Info
Gene Name	SLC25A23
Transporter Name	Calcium-binding mitochondrial carrier protein SCaMC-3
Gene ID	79085
UniProt ID	Q9BV35

Post-Translational Modification of This DT
Overview of SLC25A23 Modification Sites with Functional and Structural Information
Sequence	M R G S P G D A E R R Q R W G R L F E E L D S N K D G R V D V H E L R Q G L A R L G G G N P D P G A Q Q G I S S E G D A D P D G G L D L E E F S R Y L Q E R E Q R L L L M F H S L D R N Q D G H I D V S E I Q Q S F R A L G I S I S L E Q A E K I L H S M D R D G T M T I D W Q E W R D H F L L H S L E N V E D V L Y F W K H S T V L D I G E C L T V P D E F S K Q E K L T G M W W K Q L V A G A V A G A V S R T G T A P L D R L K V F M Q V H A S K T N R L N I L G G L R S M V L E G G I R S L W R G N G I N V L K I A P E S A I K F M A Y E Q I K R A I L G Q Q E T L H V Q E R F V A G S L A G A T A Q T I I Y P M E V L K T R L T L R R T G Q Y K G L L D C A R R I L E R E G P R A F Y R G Y L P N V L G I I P Y A G I D L A V Y E T L K N W W L Q Q Y S H D S A D P G I L V L L A C G T I S S T C G Q I A S Y P L A L V R T R M Q A Q A S I E G G P Q L S M L G L L R H I L S Q E G M R G L Y R G I A P N F M K V I P A V S I S Y V V Y E N M K Q A L G V T S R
PTM type	X-O-glycosylation X-Phosphorylation X-Ubiquitination X: Amino Acid

O-glycosylation
Serine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC25A23			[1]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	4
Experimental Method	Co-Immunoprecipitation
Detailed Description	O-linked Glycosylation at SLC25A23 Serine 4 has the potential to affect its expression or activity.
Phosphorylation
Serine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC25A23			[2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	240
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A23 Serine 240 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC25A23			[3] , [4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	409
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A23 Serine 409 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC25A23			[3] , [4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	417
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A23 Serine 417 has the potential to affect its expression or activity.
Threonine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC25A23			[5]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	308
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A23 Threonine 308 has the potential to affect its expression or activity.
Ubiquitination
Lysine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC25A23			[6]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	251
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC25A23 Lysine 251 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC25A23			[6]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	267
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC25A23 Lysine 267 has the potential to affect its expression or activity.
Tyrosine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC25A23			[7]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	298
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC25A23 Tyrosine 298 has the potential to affect its expression or activity.

References
1	A triarylphosphine-trimethylpiperidine reagent for the one-step derivatization and enrichment of protein post-translational modifications and identification by mass spectrometry. Chem Commun (Camb). 2018 Dec 6;54(98):13790-13793.
2	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
3	Citric acid-assisted two-step enrichment with TiO2 enhances the separation of multi- and monophosphorylated peptides and increases phosphoprotein profiling. J Proteome Res. 2013 Jun 7;12(6):2467-76.
4	Phosphoproteomics reveals ALK promote cell progress via RAS/ JNK pathway in neuroblastoma. Oncotarget. 2016 Nov 15;7(46):75968-75980.
5	iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
6	Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.
7	Highly Multiplexed Quantitative Mass Spectrometry Analysis of Ubiquitylomes. Cell Syst. 2016 Oct 26;3(4):395-403.e4.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence